News
Keep up to date with the latest news and updates about the ABATED study
Festival of Communities
12 June 2023
First ABATED focus group
2 November 2022
AINOSTICS granted FDA Breakthrough Device Designation
8 September 2022
AINOSTICS has been awarded Breakthrough Device Designation by the US Food and Drug Administration (FDA) to the product, BR[AI]N.
Funding to evaluate AI technology for timely and equitable dementia diagnosis
9 May 2022
ABATED Study Funding Announcement